Oliver Steinkohl

Suggest Changes
Learn More
OBJECTIVE Biomarkers uPA and PAI-1 are guideline recommended by ASCO (USA) and AGO (Germany) in primary breast cancer to avoid unnecessary CTX in patients at medium risk for recurrence. For clinical(More)
  • 1